HealthAssure
HealthAssureGood Life
LOINCActiveOrder

LOINC Code 76091-8: Respiratory pathogens DNA and RNA 4 panel NAA+probe (Nph)

76091-8 is a LOINC code used to identify Respiratory pathogens DNA and RNA 4 panel NAA+probe (Nph) in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Respiratory pathogens DNA & RNA 4 panel. It is commonly used with the system or sample type Nph.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Respiratory pathogens DNA & RNA 4 panel. It is commonly used with the system or sample type Nph.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Order vs observation: Order
  • Panel type: Panel
  • Method: Probe.amp.tar

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

Respiratory pathogens DNA and RNA 4 panel - Nasopharynx by NAA with probe detection
Respiratory pathogens DNA & RNA 4 panel
Determining the etiology of respiratory symptoms remains a clinical and laboratory challenge. Infections with respiratory syncytial virus (RSV), influenza viruses (IVs), and adenoviruses (AdVs) are traditionally diagnosed using viral culture and direct immunofluorescence (DIF) tests, however real-time PCR studies considerably increase diagnostic yields for respiratory viruses from patients with respiratory symptoms within a clinically relevant time frame, allowing clinicians to start optimal patient management, and to initiate adequate use of antiviral therapy and optimal infection control. [PMCIDPMC1932984]
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; Random; Resp path 4 Pnl; Resp path DNA+; Resp path DNA+RNA; Resp pathogens; Respiratory; Respiratory bacteria & viruses; Respiratory bacteria & viruses DNA & RNA; Ribonucleic acid; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Respiratory pathogens DNA and RNA 4 panel NAA+probe (Nph)Respiratory pathogens DNA and RNA 4 panel - Nasopharynx by NAA with probe detectionResp path 4 Pnl Nph NAA+probeRespiratory pathogens DNA & RNA 4 panelPANEL.MICRORespiratory Pathogens DNA and RNA 4 Panel, Nasopharynx-

Frequently asked questions

Code details

Code76091-8
SystemLOINC
Display nameRespiratory pathogens DNA and RNA 4 panel NAA+probe (Nph)
DescriptionRespiratory pathogens DNA & RNA 4 panel
Short nameResp path 4 Pnl Nph NAA+probe
ComponentRespiratory pathogens DNA & RNA 4 panel
Property-
TimingPt
System (specimen)Nph
Scale-
MethodProbe.amp.tar
ClassPANEL.MICRO
StatusACTIVE
Order/ObservationOrder

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.52
Last changed2.63

Consumer names

Respiratory Pathogens DNA and RNA 4 Panel, Nasopharynx

Part names

Respiratory pathogens DNA & RNA 4 panel-PtNphProbe.amp.tarRespiratory pathogens DNA and RNA 4 panelPoint in time (spot)NasopharynxNucleic acid amplification with probe detection

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.